Position in ESPR
as of Jun 30, 2026
· filed Jul 2, 2026
Position Value
$578,428
+$578,428 QoQ
Shares Held
183,047
0.0% QoQ
Ownership
0.071%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
#7
of 40 holders
Holding Since
Mar 2026
2 quarters on record
Common Shares in ESPR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Eleva Capital SAS holds $589,743 across 2 Drug Manufacturers - Specialty & Generic names. ESPR ranks #1 (98.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ESPR |
Esperion Therapeutics, Inc.
This page
|
183,047 | $578,428 | |
| 2 | AQST |
Aquestive Therapeutics, Inc.
|
2,720 | $11,315 |
All Filings in ESPR
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $578,428 | 183,047 | Shares | Sole | 2026-07-02 | |
| 2026-03-31 | — | 183,047 | Shares | Sole | 2026-04-15 | |
| No filing history on record for this holder in this stock. | ||||||